LeonaBio, Inc. (LONA)
NASDAQ: LONA · Real-Time Price · USD
7.35
-0.12 (-1.61%)
Sep 15, 2026, 2:25 PM EDT - Market open
LeonaBio Market Cap
LeonaBio has a market cap or net worth of $69.25 million as of September 15, 2026. Its market cap has increased by 387.73% in one year.
Market Cap
69.25M
Enterprise Value
18.76M
1-Year Change
387.73%
Ranking
Category
Stock Price
$7.35
ChartMarket Cap Chart
Since September 18, 2020, LeonaBio's market cap has decreased from $527.32M to $69.25M, a decrease of -86.87%. That is a compound annual growth rate of -28.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 69.25M | 131.95% |
| Dec 31, 2025 | 29.86M | 31.60% |
| Dec 31, 2024 | 22.69M | -75.47% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cingulate | 75.18M |
| BioStem Technologies | 75.15M |
| OKYO Pharma | 73.47M |
| NeurAxis | 72.21M |
| Pliant Therapeutics | 71.21M |
| Champions Oncology | 68.36M |
| Rein Therapeutics | 68.24M |
| Alterity Therapeutics | 66.92M |